Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Everything You Need to Know About Supervision

Feb 1, 2025/Feature

Changes to Medicare in 2025 will impact requirements for PT supervision of PTAs. Do they make direct supervision obsolete?

Exploring Pain

Sep 20, 2022/Video

Discover the latest insights and groundbreaking approaches that are shaping the present and future of pain management.

Collaboration, Compassion, and Community: Establishing an APTA State Chapter-Affiliated Pro Bono Clinic

Jun 18, 2024/Perspective

Samuel O’Melia, PT, DPT, shares the experience of APTA Alaska in establishing a community clinic, with advice for other chapters that might want to do the same.

Prevention and Wellness

Research continues to show the significant benefits of lifestyle changes on health.

Helping You Thrive

We provide you with pathways for success throughout your career journey.

APTA Continues Fighting For Federal Student Loan Access for Future PTs

Apr 1, 2026/News

The American Physical Therapy Association continues its advocacy against the U.S. Department of Education's proposal that would sharply limit federal student loan access for doctor of physical therapy students and students seeking degrees in dozens of other professions. With the department expected to

Passive Head-Shaking Nystagmus Test (pHSN)

Jun 7, 2017/Test & Measure

Assesses for latent spontaneous vestibular nystagmus through rapid, passive, head shaking around a vertical axis for the detection of vestibulopathies in dizzy patients.

What Is PTPAC? Five Things You Need to Know

Feb 3, 2023/News

Our political action committee is working on issues that matter now and into the profession's future.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).